TTK Healthcare Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast

TTK Healthcare at Rs 1059.0 is a pharma and healthcare company whose share price target of Rs 1,110 for 2027 represents approximately 12 percent upside from the current market price. The TTK Healthcare share price target rises to Rs 1,210 by 2028 and Rs 1,440 by 2030, implying a 4-year upside of approximately 45 percent from August 2026 levels. FY26 EPS of ₹56.6 growing approximately9% a year, capitalised at approximately18x forward earnings; growth tapers to approximately7% further out..

The targets are derived from the analyst consensus and forward earnings model based on FY26 financials. This article covers the TTK Healthcare share price target 2027, 2028, and 2030 as of August 2026 to help investors evaluate the long-term investment case.

Click Here – Get Free Investment Predictions

TTK Healthcare Company Overview

Metric	Details
NSE Ticker	TTKHLTCARE
Sector	Pharma and Healthcare
CMP (10 Aug 2026)	Rs 1059.0
Market Cap	Rs 1297 Cr
FY26 EPS	Rs 56.6 (9% annual growth)
TTK Healthcare Share Price Target 2027	Rs 1,110 (+12%)
TTK Healthcare Share Price Target 2028	Rs 1,210 (+22%)
TTK Healthcare Share Price Target 2030	Rs 1,440 (+45%)
Bull Case 2030	Rs 1,843
Bear Case 2030	Rs 1,080

What most investors miss: Owns TTK Chitra, one of the few Indian-made artificial heart valve brands – a niche medical-device asset embedded within a consumer-healthcare portfolio; market cap down approximately30% in 1 year

FY26 EPS of ₹56. 6 growing approximately9% a year, capitalised at approximately18x forward earnings; growth tapers to approximately7% further out. The share price target of Rs 1,110 for 2027 and Rs 1,440 for 2030 reflect this earnings trajectory.

Why Is the TTK Healthcare Share Price Target Set at Rs 1,110 for 2027

Domestic Branded Formulations Revenue Growth

This is the primary driver of the TTK Healthcare share price target for 2027 and 2030. FY26 EPS of ₹56.6 growing approximately9% a year, capitalised at approximately18x forward earnings; growth tapers to approximately7% further out.. Investors tracking this metric quarterly will have the earliest signal of whether the TTK Healthcare share price target timeline is on track.

Export Markets and Regulatory Compliance Track Record

The TTK Healthcare share price target of Rs 1,110 for 2027, rising to Rs 1,440 by 2030, assumes this factor remains intact and compounds through the forecast period. Any deterioration in this dimension would be the earliest warning for the TTK Healthcare share price target thesis.

Product Pipeline and New Launch Capability

This structural factor underpins the long-term TTK Healthcare share price target of Rs 1,440 by 2030 beyond the near-term 2027 milestone. Its persistence through economic cycles is what differentiates this investment from a purely cyclical trading position.

Manufacturing Scale and Cost Efficiency

For the TTK Healthcare share price target to materialise, this factor must continue to hold and improve through FY27 to FY31. It provides the margin of safety for the Rs 1,210 target in 2028 when earnings quality is most clearly visible.

India's Healthcare Spending Growth Is a Structural Tailwind

India's long-term economic growth trajectory creates a secular tailwind for TTK Healthcare's business that amplifies the company-specific earnings compounding embedded in the TTK Healthcare share price target 2030 of Rs 1,440 (+45% from CMP Rs 1059.0).

TTK Healthcare Share Price Targets 2027, 2028 and 2030

TTK Healthcare Share Price Target 2027: Rs 1,110

The TTK Healthcare share price target 2027 is Rs 1,110, representing approximately 12 percent upside from CMP Rs 1059.0. FY26 EPS of ₹56.6 growing approximately9% a year, capitalised at approximately18x forward earnings; growth tapers to approximately7% further out.. The primary catalyst for achieving the 2027 target is consistent quarterly earnings delivery that validates the analyst model underpinning the TTK Healthcare share price target.

TTK Healthcare Share Price Target 2028: Rs 1,210

The TTK Healthcare share price target 2028 is Rs 1,210, implying approximately 22 percent upside from CMP. By FY29, TTK Healthcare should have demonstrated through a complete earnings cycle that the forward growth assumptions are sustainable. This two-year validation of the TTK Healthcare share price target thesis typically triggers institutional re-rating toward the Rs 1,210 level.

TTK Healthcare Share Price Target 2030: Rs 1,440

The TTK Healthcare share price target 2030 is Rs 1,440, implying approximately 45 percent upside from CMP and a 4-year CAGR of approximately 8 percent. By FY31, TTK Healthcare should be operating as a mature business with a track record of consistent compounding, justifying the target multiple. Always verify data at NSE and BSE before acting on analyst price targets.

Bull Case and Bear Case for TTK Healthcare Share Price Target 2030

Bull Case: Rs 1,843

The bull case TTK Healthcare share price target of Rs 1,843 by 2030 requires earnings growth to exceed the base case projection and the market to re-rate the stock to a higher-than-consensus multiple. Favourable macro conditions, new product or geographic expansion wins, and sustained margin improvement would drive this upside scenario.

Bear Case: Rs 1,080

The bear case TTK Healthcare share price target of Rs 1,080 by 2030 applies if earnings growth disappoints relative to analyst expectations, competitive pressure intensifies, or a macro slowdown compresses the sector multiple. Even in this scenario, the downside reflects a more conservative earnings assumption rather than a fundamental business failure.

Scenario	Target 2030	Return
Bull Case	Rs 1,843	+74%
Base Case	Rs 1,440	+45%
Bear Case	Rs 1,080	+2%

Key Risks to the TTK Healthcare Share Price Target

USFDA Compliance and Inspection Risk

Any regulatory action on TTK Healthcare's manufacturing facilities could delay product launches and reduce the TTK Healthcare share price target earnings.

Currency Risk on Export Revenue

INR appreciation against USD and EUR reduces the INR value of TTK Healthcare's international revenues and the TTK Healthcare share price target EPS.

Generic Pricing Pressure in Export Markets

Intensifying competition in US and European generic markets compresses pricing and the TTK Healthcare share price target margin assumptions.

Clinical and Approval Timeline Risk

Delays in pipeline product approvals would push revenue ramp-up beyond the TTK Healthcare share price target timeline.

How to Invest in TTK Healthcare

Use the Univest Screener to track TTK Healthcare's quarterly earnings, key sector-specific metrics, and analyst upgrades in real time. To purchase shares, open a demat account with any SEBI-registered broker and search for NSE ticker TTKHLTCARE. Review the quarterly earnings data and the risk factors outlined in this article before committing capital. Build positions gradually and align the holding period to the TTK Healthcare share price target 2030 timeline of approximately 4 years. Consult a SEBI-registered financial advisor before investing.

Use the Univest Screener to Track This Stock Live

Conclusion

The TTK Healthcare share price target of Rs 1,110 for 2027, Rs 1,210 for 2028, and Rs 1,440 for 2030 reflects analyst consensus earnings compounding in the pharma and healthcare sector. The 4-year upside of approximately 45 percent from CMP Rs 1059.0 assumes the business delivers on the growth drivers outlined above and maintains the valuation multiple consistent with sector peers. Always verify financial data at NSE India and BSE before making any investment decision.

Download the Univest iOS App or Univest Android App to track TTK Healthcare share price live and get daily stock recommendations.

Frequently Asked Questions on TTK Healthcare Share Price Target 2027 2028 and 2030

What is the TTK Healthcare share price target for 2027?

Ans. The TTK Healthcare share price target for 2027 is Rs 1,110, representing approximately 12 percent upside from CMP Rs 1059.0 as of August 2026. Please verify all data at NSE India before investing.

What is the TTK Healthcare share price target for 2030?

Ans. The TTK Healthcare share price target for 2030 is Rs 1,440, implying approximately 45 percent upside from CMP Rs 1059.0. This reflects the analyst consensus extrapolated at the projected growth rate. These are estimates, not guaranteed returns.

What is the TTK Healthcare share price target for 2028?

Ans. The TTK Healthcare share price target for 2028 is Rs 1,210, implying approximately 22 percent upside from CMP. By 2028, two full years of earnings delivery should validate the analyst model and support a re-rating toward this level.

Is TTK Healthcare a good long-term investment?

Ans. TTK Healthcare has a defined analyst projection for earnings compounding through FY31 in the pharma and healthcare sector. Whether it suits your portfolio depends on your risk appetite, investment horizon, and sector allocation. Consult a SEBI-registered financial advisor before investing.

What are the key risks to the TTK Healthcare share price target?

Ans. Key risks include sector-specific headwinds such as usfda compliance and inspection risk, currency risk on export revenue, and broader macro slowdowns. Please review the full risks section in this article before investing.

What is the bull case for TTK Healthcare share price by 2030?

Ans. The bull case TTK Healthcare share price target for 2030 is Rs 1,843, requiring earnings growth above the base case and a higher PE multiple. This scenario needs favourable execution and sector conditions. These are analyst projections, not guaranteed returns.

What is TTK Healthcare's current market cap?

Ans. TTK Healthcare has a market cap of approximately Rs 1297 crore as of August 2026 based on the data available. Verify the current market cap at NSE India or BSE before making investment decisions.

How can I invest in TTK Healthcare?

Ans. You can buy TTK Healthcare shares through any SEBI-registered broker by searching for NSE ticker TTKHLTCARE. Review the fundamentals and risk factors before investing, and consult a SEBI-registered financial advisor for personalised guidance.